Tumor necrosis factor-α levels and promoter polymorphism in patients with Kawasaki disease in Korea

Yonsei Medical Journal

Volumn 44, Issue 6, 2003, Pages 1021-1026

  Ahn, Sun Young ^a   Jang, Gwang Cheon ^a   Shin, Jeon Soo ^a   Shin, Kyung Mi ^a   Kim, Dong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Kawasaki disease; Polymorphism; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA POLYMORPHISM; ELECTIVE SURGERY; GENE FREQUENCY; HUMAN; KOREA; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PROMOTER REGION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC VASCULITIS;

EID: 0347126313     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.6.1021     Document Type: Article

References (20)

1. Leung DYM, Geha RS, Newberger JW, Burns JC, Fiers W, Lapierre LA, et al. Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986; 164:1958-72.
2. Lin CY, Lin CC, Hwang B, Chiang BN. The changes of interleukin-2, tumor necrotic factor and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr 1991;41:179-82.
3. Kim DS. Serum IL-6 in Kawasaki disease. Yonsei Med J 1992;32:183-8.
4. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-10.
5. Wilson AG, Gordon C, diGiovine FS, deVries N, van de Putte LB, Emery P, et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994;24:191-5.
6. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences. TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-6.
7. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995-1996;46:32-41.
8. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 1995;42:501-4.
9. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988;48:247-51.
10. Hohler T, Kruger A, Gerken G, Schneider PM, Meyerzum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998;111:579-82.
11. Turner D, Choudhury F, Reynard M, Railton D, Navarrete C. Typing of multiple single nucleotide polymorphisms in cytokine and receptor genes using sNaPshot. Hum Immunol 2002;63:508-13.
12. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;41:251-3.
13. Abraham LJ, French MA, Dawkins RL. Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-alpha. Clin Exp Immunol 1993;92:14-8.
14. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998;51:605-12.
15. Hohler T, Kruger A, Gerken G, Schneider PM, Meyerzum Buschenefelde KH, Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 1998;54:173-7.
16. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcription activation. Proc Natl Acad Sci USA 1997;94:3195-9.
17. Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, et al. HLA antigens in Kawasaki disease. Pediatrics 1978;61:252-5.
18. Barron KS, Silverman ED, Gonzales JC, St Clair M, Anderson K, Reveille JD. Major histocompatibility complex class II alleles in Kawasaki syndrome - lack of consistent correlation with disease or cardiac involvement. J Rheumatol 1992;19:1790-3.
19. Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroupe C, Shike H, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res 2001; 49:686-90.
20. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease. Pediatr Int 1999;41:341-5.